Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …

Post-thrombotic syndrome (PTS) is a common and potentially debilitating complication of
deep vein thrombosis (DVT), affecting up to 50% of DVT patients. The consequence of this …

The novel direct oral anticoagulants (DOAC) have been shown to be at least as effective as
and safer than conventional anticoagulants for the initial and long-term treatment of venous …

Although substantial progress has been made in the pathophysiology and management of
the post-thrombotic syndrome (PTS), several aspects still need clarification. Among them …

Chronic venous disorder (CVD) is highly prevalent vascular disorder affecting up to 45% of
the general population, with clinical manifestations ranging from teleangiectasias to venous …

Background: Post-thrombotic syndrome (PTS) is the most common long-term complication of
acute deep venous thrombosis (DVT). The cumulative incidence of PTS in the first two years …

Venous disease is prevalent, undertreated, and frequently unrecognized. During the past
two decades, new treatment modalities have changed how venous disease is approached …

Acute deep vein thrombosis (DVT) causes substantial short-term and long-term patient
morbidity. Medical, lifestyle, and compressive therapies have been investigated for the …

Background Post-thrombotic syndrome (PTS) is the main long-term complication of deep
vein thrombosis (DVT). Several therapies are being evaluated to prevent or to treat PTS …

Venous thromboembolism (VTE) is associated with significant morbidity and mortality.
Accuracy of diagnosis is thus of vital importance. Failure to diagnose VTE increases the risk …